Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis-Reference-Cited by-同舟云学术

Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis

Published:2022-02-07 Issue: Volume: Page:
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Sanyal Arun J.¹,Anstee Quentin M.²^ORCID,Trauner Michael³,Lawitz Eric J.⁴,Abdelmalek Manal F.⁵⁶,Ding Dora⁷,Han Ling⁷,Jia Catherine⁷,Huss Ryan S.⁷,Chung Chuhan⁷,Wong Vincent Wai‐Sun⁸^ORCID,Okanoue Takeshi⁹,Romero‐Gomez Manuel¹⁰,Muir Andrew J.⁵⁶^ORCID,Afdhal Nezam H.¹¹,Bosch Jaime¹²¹³,Goodman Zachary¹⁴,Harrison Stephen A.¹⁵,Younossi Zobair M.¹⁴^ORCID,Myers Robert P.⁷

Affiliation:

1. Virginia Commonwealth University Richmond Virginia USA

2. Translational & Clinical Research Institute Faculty of Medical Sciences Newcastle University Newcastle upon Tyne UK

3. Division of Gastroenterology and Hepatology Medical University of Vienna Vienna Austria

4. Texas Liver Institute University of Texas Health San Antonio San Antonio Texas USA

5. Duke University Medical Center Durham North Carolina USA

6. Indiana University Medical Center Indianapolis Indiana USA

7. Gilead Sciences, Inc. Foster City California USA

8. Department of Medicine and Therapeutics The Chinese University of Hong Kong Hong Kong

9. Saiseikai Suita Hospital Suita City, Osaka Japan

10. Institute of Biomedicine of Seville Virgen del Rocio University Hospital University of Seville Sevilla Spain

11. Beth Israel Deaconess Medical Center and Harvard Medical School Boston Massachusetts USA

12. Hospital Clinic‐IDIBAPS University of Barcelona Barcelona Spain

13. Department of Biomedical Research Bern University Bern Switzerland

14. Inova Fairfax Medical Campus Falls Church Virginia USA

15. Pinnacle Clinical Research San Antonio Texas USA

Funder

Gilead Sciences

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.32204

Reference20 articles.

1. Liver cirrhosis;Tsochatzis EA;Lancet,2014

2. Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta‐analysis;Taylor RS;Gastroenterology,2020

3. The natural history of advanced fibrosis due to nonalcoholic steatohepatitis: data from the simtuzumab trials;Sanyal AJ;Hepatology,2019

4. Fibrosis severity as a determinant of cause‐specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi‐national cohort study;Vilar‐Gomez E;Gastroenterology,2018

5. Design and validation of a histological scoring system for nonalcoholic fatty liver disease;Kleiner DE;Hepatology,2005

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A data-driven approach to decode metabolic dysfunction-associated steatotic liver disease;Annals of Hepatology;2024-03

2. Derivation and validation of Transform equations to convert historical Enhanced liver fibrosis (ELF) scores to modern equivalents;Clinica Chimica Acta;2024-01

3. AASLD practice guidance on risk stratification and management of portal hypertension and varices in cirrhosis;Hepatology;2023-10-23

4. A revisit of drugs and potential therapeutic targets against non-alcoholic fatty liver disease: learning from clinical trials;Journal of Endocrinological Investigation;2023-10-15

5. Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease;Nature Reviews Gastroenterology & Hepatology;2023-10-05